UFP Technologies Inc. Files Definitive Proxy Statement

TL;DR

<b>UFP Technologies Inc. has filed its Definitive Proxy Statement for the period ending June 5, 2024.</b>

AI Summary

UFP TECHNOLOGIES INC (UFPT) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. UFP Technologies Inc. filed a Definitive Proxy Statement (DEF 14A) on April 26, 2024. The filing covers the period ending June 5, 2024. The company's principal executive offices are located at 100 Hale Street, Newburyport, MA 01950. The fiscal year end for UFP Technologies Inc. is December 31. The company is incorporated in Delaware.

Why It Matters

For investors and stakeholders tracking UFP TECHNOLOGIES INC, this filing contains several important signals. This filing is a routine requirement for publicly traded companies to inform shareholders about upcoming meetings and matters to be voted upon. Shareholders will be informed about executive compensation, director elections, and other corporate governance issues.

Risk Assessment

Risk Level: low — UFP TECHNOLOGIES INC shows low risk based on this filing. The filing is a standard DEF 14A, indicating routine corporate governance and shareholder communication, with no immediate financial or operational red flags.

Analyst Insight

Review the proxy statement for details on executive compensation, director nominations, and any shareholder proposals to understand potential impacts on corporate strategy and governance.

Key Numbers

• 2024-06-05 — Reporting Period End (Conformed Period of Report)
• 2024-04-26 — Filing Date (Filed as of Date)
• 1231 — Fiscal Year End (Fiscal Year End)

Key Players & Entities

• UFP TECHNOLOGIES INC (company) — Filer
• 100 HALE STREET (location) — Business Address
• NEWBURYPORT (location) — Business Address City
• MA (location) — Business Address State
• 01950 (location) — Business Address Zip
• DE (location) — State of Incorporation

FAQ

Industry Context

UFP Technologies Inc. operates in the Surgical & Medical Instruments & Apparatus industry (SIC 3841).

Regulatory Implications

The filing is a DEF 14A, a standard SEC form required for proxy solicitations under the Securities Exchange Act of 1934.

What Investors Should Do

1. Review the full DEF 14A filing for detailed information on executive compensation packages.
2. Examine the election of directors and any proposed amendments to corporate governance policies.
3. Note any shareholder proposals and the company's recommendation on how to vote.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a routine disclosure and does not represent a change from previous filings of the same type.

Key Financial Figures

• $0.01 — e 7,670,487 shares of our Common Stock, $0.01 par value (the "Common Stock"). Each su
• $2.5 billion — tional focus to integrate Maxim Inc., a $2.5 billion business acquired by ADI in August 2021
• $1.8 Billion — anchises and Innovation for ConvaTec, a $1.8 Billion international medical products and tech
• $10.7 billion — ic leadership roles for Baxter, Inc., a $10.7 billion company that develops, manufactures, an
• $4 billion — mation for Hospira, Inc (now Pfizer), a $4 billion world leader in specialty generic injec
• $8 billion — eadership roles for Aon Corporation, an $8 billion risk management, retail, reinsurance &
• $100 — Vice President and General Manager of a $100+ million business unit. Mr. Cardin joi

Filing Documents

• ufpt20240425_def14a.htm (DEF 14A) — 609KB
• peoavneo.jpg (GRAPHIC) — 30KB
• peovsnetinc.jpg (GRAPHIC) — 29KB
• peovsop.jpg (GRAPHIC) — 32KB
• proxy_01.jpg (GRAPHIC) — 138KB
• proxy_02.jpg (GRAPHIC) — 112KB
• ufpvspeer.jpg (GRAPHIC) — 24KB
• 0001171843-24-002290.txt (&nbsp;) — 2103KB
• ufpt-20231231.xsd (EX-101.SCH) — 3KB
• ufpt-20231231_def.xml (EX-101.DEF) — 2KB
• ufpt-20231231_lab.xml (EX-101.LAB) — 2KB
• ufpt-20231231_pre.xml (EX-101.PRE) — 1KB
• ufpt20240425_def14a_htm.xml (XML) — 117KB

From the Filing

ufpt20240425_def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a 6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under 240.14a12 UFP TECHNOLOGIES, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 UFP TECHNOLOGIES, INC. 100 HALE STREET NEWBURYPORT, MASSACHUSETTS 01950 3504 USA NOTICE OF ANNUAL MEETING OF STOCKHOLDERS of UFP TECHNOLOGIES, INC. To Be Held on June 5, 2024 The Annual Meeting of Stockholders of UFP Technologies, Inc. ("we," "us," "our," or the "Company") will be held on June 5, 2024, at 10:00 a.m., Eastern Daylight Time. There will be no physical meeting location. The Annual Meeting will be a virtual stockholder meeting, conducted via live audio webcast, through which you can submit questions and vote online. The Annual Meeting can be accessed by visiting http://www.virtualshareholdermeeting.com/UFPT2024 and entering your 16-digit control number included in your proxy materials or on your proxy card. The Annual Meeting will be for the following purposes: 1. To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected; 2. To vote on a nonbinding advisory resolution to approve the compensation of our named executive officers; 3. To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2024; and 4. To transact such other business as may properly come before the 2024 Annual Meeting of Stockholders, and at any adjournment or postponement thereof. The Board of Directors has fixed April 11, 2024 as the record date for determining the stockholders entitled to notice of, and to vote at, the Annual Meeting. It is expected that this proxy statement and the accompanying proxy will be mailed to stockholders on or about May 3, 2024. You are cordially invited to attend the virtual Annual Meeting. By Order of the Board of Directors Christopher P. Litterio Secretary Newburyport, Massachusetts April 26, 2024 1 YOUR VOTE IS IMPORTANT YOU ARE URGED TO VOTE, SIGN, DATE, AND RETURN THE ACCOMPANYING ENCLOSED PROXY AS PROMPTLY AS POSSIBLE IN THE POSTAGE PAID ENVELOPE ENCLOSED FOR THAT PURPOSE. EVEN IF YOU HAVE GIVEN YOUR PROXY, THE PROXY MAY BE REVOKED AT ANY TIME PRIOR TO THE EXERCISE BY FILING WITH THE SECRETARY OF THE COMPANY A WRITTEN REVOCATION, BY EXECUTING A PROXY WITH A LATER DATE, OR BY ATTENDING AND VOTING AT THE VIRTUAL ANNUAL MEETING. IMPORTANT NOTICE REGARDING AVAILABILITY OF PROXY MATERIALS FOR OUR ANNUAL MEETING OF STOCKHOLDERS TO BE HELD VIRTUALLY ON JUNE 5, 2024: This Proxy Statement, our Annual Report for the fiscal year ended December 31, 2023 and the Proxy Card are available at our website, www.ufpt.com/investors/filings.html. UFP TECHNOLOGIES, INC. 100 HALE STREET NEWBURYPORT, MASSACHUSETTS 01950 3504 USA PROXY STATEMENT FOR THE ANNUAL MEETING OF STOCKHOLDERS To Be Held on June 5, 2024 This proxy statement is furnished in connection with the solicitation of proxies by the Board of Directors (the "Board") of UFP Technologies, Inc., a Delaware corporation ("we," "us," "our," or the "Company"), with its principal executive offices at 100 Hale Street, Newburyport, MA 019503504, for use at the Annual Meeting of Stockholders to be held on June 5, 2024, and at any adjournment or postponement thereof (the "Meeting"). The enclosed proxy relating to the Meeting is solicited on behalf of our Board of Directors and the cost of such solicitation will be borne by us. It is expected that this proxy statement and the accompanying proxy will be mailed to stockholders on or about May 3, 2024. Certain of our officers and employees may solicit proxies by correspondence, telephone or in person, without extra compensation. We may also pay to banks, brokers, nominees and certain other fiduciaries their reasonable expenses incurred in forwarding proxy material to the beneficial owners of securities held by them. Only stockholders of record at the close of business on April 11, 2024 will be entitled to receive notice of, and to vote at, the Meeting. As of that date, there were outstanding and entitled to vote 7,670,487 shares of our Common Stock, $0.01 par value (the

View Full Filing

View this DEF 14A filing on SEC EDGAR